Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
affirmative, anniversary, arrangement, contingent, customary, David, fourth, Glenn, Iran, launched, MFA, Rule, satisfaction, satisfy, soluble, unrecognized
Removed:
discontinued, disposal, eighteen, model, twelve
Financial report summary
?Risks
- Risk Factors Relating to Our Business
- Outbreaks of animal diseases could significantly reduce demand for our products.
- Perceived adverse effects on human health linked to the consumption of food derived from animals that utilize our products could cause a decline in the sales of those products.
- A material portion of our sales are generated by antibacterials and other related products.
- Our business may be negatively affected by weather conditions and the availability of natural resources.
- A pandemic, epidemic, or outbreak of an infectious disease in humans, such as COVID-19, may materially and adversely affect our business and our financial results.
- Climate change could have a material adverse impact on our operations and our customers’ businesses.
- The testing, manufacturing and marketing of certain of our products are subject to extensive regulation by numerous government authorities in the United States and other countries, including, but not limited to, the FDA.
- We may experience declines in the sales volume and prices of our products as the result of the continuing trend toward consolidation of certain customer and distributor groups as well as the emergence of large buying groups.
- Our business is subject to risk based on customer exposure to rising costs and reduced customer income.
- Generic products may be viewed as more cost-effective than certain of our products.
- Advances in veterinary medical practices and animal health technologies could negatively affect the market for our products.
- The misuse or extra-label use of our products may harm our reputation or result in financial or other damages.
- The public perception of the safety, quality and efficacy of certain of our animal health products may harm our reputation.
- We are dependent on suppliers having current regulatory approvals, and the failure of those suppliers to maintain these approvals or other challenges in replacing any of those suppliers could affect our supply of materials or affect the distribution or sale of our products.
- The raw materials used by us and our third-party contract manufacturers in the manufacture of our products can be subject to price fluctuations and their availability can be limited.
- Our revenues are dependent on the continued operation of our various manufacturing facilities.
- We could be subject to changes in our tax rates, the adoption of new U.S. or foreign tax legislation or exposure to additional tax liabilities.
- A significant portion of our operations are conducted in foreign jurisdictions and are subject to the economic, political, legal and business environments of the countries in which we do business.
- We are subject to product registration and authorization regulations in many of the jurisdictions in which we operate and/or distribute our products, including the United States and member states of the European Union.
- We have significant assets located outside the United States and a significant portion of our sales and earnings is attributable to operations conducted abroad that may be adversely affected by foreign currency exchange rate fluctuations and other inherent risks.
- We have manufacturing facilities located in Israel and a portion of our net sales and earnings is attributable to products produced and operations conducted in Israel.
- We have manufacturing facilities located in Brazil and a portion of our sales and earnings is attributable to products produced and operations conducted in Brazil.
- Certain of our employees are covered by collective bargaining or other labor agreements.
- The loss of key personnel may disrupt our business and adversely affect our financial results.
- Our R&D relies on evaluations in animals, which may become subject to bans or additional regulations.
- Our operations, properties and subsidiaries are subject to a wide variety of complex and stringent federal, state, local and foreign environmental laws and regulations.
- Our operations or products may impact the environment or cause or contribute to contamination or exposure to hazardous substances.
- We are subject to risks from litigation that may materially impact our operations.
- We are subject to risks that may not be covered by our insurance policies.
- Adverse U.S. and international economic and market conditions may adversely affect our product sales and business.
- We may not be able to realize the expected benefits of our investments in emerging markets.
- Modification of foreign trade policy may harm our food animal product customers.
- Our product approval, R&D, acquisition and licensing efforts may fail to generate new products and product lifecycle developments.
- The actual or purported intellectual property rights of third parties may negatively affect our business.
- If our intellectual property rights are challenged or circumvented, competitors may be able to take advantage of our R&D efforts. We are also dependent upon trade secrets, which in some cases may be difficult to protect.
- Increased regulation or decreased governmental financial support for the raising, processing or consumption of food animals could reduce demand for our animal health products.
- We may not be able to generate sufficient cash to service all of our indebtedness and may be forced to take other actions to satisfy our obligations under our indebtedness, which may not be successful.
- We are subject to change of control provisions.
- We depend on sophisticated information technology and infrastructure.
- We may be required to write down goodwill or identifiable intangible assets.
- We may be unable to adequately protect our customers’ privacy or we may fail to comply with privacy laws.
- We may be subject to information technology system failures, network disruptions and breaches in data security.
- Risks Related to Ownership of Our Class A Common Stock
- Our stock price may be volatile or may decline regardless of our operating performance.
- Our majority stockholder has the ability to control significant corporate activities and our majority stockholder’s interests may not coincide with yours.
- Future sales of our Class A common stock, or the perception in the public markets that these sales may occur, may depress our stock price.
- Anti-takeover provisions in our charter documents and Delaware law might discourage or delay acquisition attempts for us that you might consider favorable.
- Provisions of our certificate of incorporation could have the effect of preventing us from having the benefit of certain business opportunities that we would otherwise be entitled to pursue.
- We may not pay cash dividends in the future and, as a result, you may not receive any return on investment unless you are able to sell your Class A common stock for a price greater than your initial investment.
- We face competition in each of our markets from a number of large and small companies, some of which have greater financial, R&D, production and other resources than we have.
- Failure to comply with requirements to design, implement and maintain effective internal controls could have a material adverse effect on our business and stock price.
- As a public company, we are subject to financial and other reporting and corporate governance requirements that may be difficult for us to satisfy and may divert management’s attention from our business.
- We may not be able to expand through acquisitions or successfully integrate the products, services and personnel of acquired businesses.
- We may not successfully implement our business strategies or achieve expected gross margin improvements.